Baxter International (NYSE:BAX) Updates FY 2025 Earnings Guidance

Baxter International (NYSE:BAX) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 2.450-2.550 for the period, compared to the consensus estimate of 2.460. The company issued revenue guidance of $11.2 billion-$11.3 billion, compared to the consensus revenue estimate of $11.2 billion. Baxter International also updated its Q1 2025 guidance to 0.470-0.500 EPS.

Analysts Set New Price Targets

BAX has been the topic of several recent analyst reports. StockNews.com cut shares of Baxter International from a “buy” rating to a “hold” rating in a research report on Monday, November 11th. Stifel Nicolaus dropped their price objective on Baxter International from $46.00 to $38.00 and set a “buy” rating on the stock in a report on Monday, November 11th. Barclays assumed coverage on shares of Baxter International in a research report on Thursday. They set an “overweight” rating and a $39.00 price target for the company. Citigroup decreased their price objective on shares of Baxter International from $37.00 to $35.00 and set a “neutral” rating on the stock in a research report on Wednesday, December 11th. Finally, JPMorgan Chase & Co. dropped their price target on Baxter International from $38.00 to $36.00 and set a “neutral” rating for the company in a research note on Friday. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $38.80.

Baxter International Trading Up 0.9 %

Shares of BAX traded up $0.29 during trading hours on Friday, reaching $33.73. 1,935,334 shares of the company traded hands, compared to its average volume of 4,766,608. Baxter International has a 12 month low of $28.33 and a 12 month high of $44.01. The company has a market capitalization of $17.22 billion, a price-to-earnings ratio of 168.38, a price-to-earnings-growth ratio of 9.83 and a beta of 0.61. The company’s fifty day moving average price is $30.57 and its two-hundred day moving average price is $34.14. The company has a quick ratio of 1.09, a current ratio of 1.43 and a debt-to-equity ratio of 1.31.

Baxter International (NYSE:BAX) last issued its quarterly earnings results on Thursday, February 20th. The medical instruments supplier reported $0.58 EPS for the quarter, topping analysts’ consensus estimates of $0.52 by $0.06. Baxter International had a return on equity of 18.30% and a net margin of 0.77%. The firm had revenue of $2.75 billion for the quarter, compared to analysts’ expectations of $2.67 billion. Equities research analysts predict that Baxter International will post 1.83 earnings per share for the current fiscal year.

Baxter International Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 1st. Stockholders of record on Friday, February 28th will be given a $0.17 dividend. The ex-dividend date of this dividend is Friday, February 28th. This represents a $0.68 annualized dividend and a dividend yield of 2.02%. Baxter International’s payout ratio is 340.02%.

Baxter International Company Profile

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.